insights_auto
Why is AVXL down 13,77%?
Dive Deeperchevron_right
AVXL:NASDAQ
Anavex Life Sciences Corp
2,04 $
arrow_downward
-13,77%(-0,32) 1D
30 սեպ, 15:44:41 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AVXL...
Open
2,38 $
High
2,38 $
Low
1,89 $
Mkt. cap
188,64 մլն
Avg. vol.
757,88 հզր
Volume
2,30 մլն
52-wk high
10,38 $
52-wk low
1,89 $
EPS
-0,15 $
Beta
1,14
Shares outstanding
92,70 մլն
No. of employees
34
Open
2,38 $
High
2,38 $
Low
1,89 $
Mkt. cap
188,64 մլն
Avg. vol.
757,88 հզր
Volume
2,30 մլն
52-wk high
10,38 $
52-wk low
1,89 $
EPS
-0,15 $
Beta
1,14
Shares outstanding
92,70 մլն
No. of employees
34
News stories
From web sources and news partners
Morningstar
·
2 ժամ առաջ
AVXL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Anavex (NASDAQ: AVXL) Investors of Securities Class Action Lawsuit Deadline on November 30, 2026
Business Wire
·
4 ժամ առաջ
AVXL Investors Have Opportunity to Lead Anavex Life Sciences Corp. Securities Fraud Lawsuit with SBS Law
Business Wire
·
19 ժամ առաջ
EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of Anavex Life Sciences Corp. Investors – AVXL
Investing.com Nigeria
·
1 օր առաջ
Form 4 Anavex Life Sciences Corp For: 28 September By Investing.com
About Anavex Life Sciences Corp
CEOChristopher U. Missling Ph.D.
Employees34
Founded2004
HeadquartersՆյու Յորք, Նյու Յորք, Միացյալ Նահանգներ
Sector-
Websiteanavex.com